AMBARELLA INC quarterly report, Q3 FY2022

Ambarella, Inc. — Q3 FY2022 Form 10-Q

Reporting period: Quarter and nine months ended October 31, 2021; comparisons are with the corresponding 2020 periods. Amounts are in U.S. dollars. Ambarella develops low-power semiconductor solutions for video processing and AI/computer vision applications.

Key financial metrics

MetricThree months ended Oct. 31, 2021Nine months ended Oct. 31, 2021
Revenue$92.2 million, up 64.3%$241.6 million, up 50.2%
Gross profit / gross margin$57.6 million / 62.5%$150.8 million / 62.4%
Operating expenses$58.8 million$168.1 million
Operating income (loss)$(1.2) million$(17.3) million
Net income (loss)$0.8 million; diluted EPS $0.02$(17.2) million; diluted EPS $(0.47)
Cash from operationsNot separately reported for the quarter$18.2 million

At October 31, 2021, cash and cash equivalents were $457.8 million, with no marketable debt securities remaining after liquidation of the investment portfolio. Current assets were $555.4 million and current liabilities $81.6 million. Total liabilities were $104.1 million; the filing reports lease and software-license liabilities but no borrowings. Cash, cash equivalents and marketable securities totaled $457.8 million, compared with $440.7 million at January 31, 2021.

Changes and business drivers

  • Revenue growth reflected increased adoption of computer-vision products in IP security and automotive camera markets; growth in these areas more than offset lower consumer-camera revenue.
  • Gross margin improved from 62.0% to 62.5% for the quarter and from 60.8% to 62.4% for the nine-month period. Management cited a higher share of automotive revenue and regional/customer mix in professional IP security.
  • Operating losses narrowed substantially year over year as higher revenue and gross profit outweighed increased expenses. R&D and SG&A increased, mainly due to personnel, engineering and business-development costs.
  • Nine-month operating cash flow was essentially flat year over year ($18.2 million versus $18.3 million). Higher receivables and inventory, including inventory built in response to longer supply-chain lead times, used cash.
  • Investing cash flow was $190.9 million provided, mainly reflecting sales and maturities of debt securities; it is not a measure of recurring operating cash generation.

Outlook, risks and unusual items

  • No specific revenue or earnings guidance is provided in the supplied filing text. Management expects R&D spending to increase as it develops computer-vision products and targets automotive, robotics and other markets; it also expects operating and capital expenditures to rise with growth.
  • On November 5, 2021, after quarter-end, Ambarella completed its acquisition of Oculii for $307.5 million in cash, subject to customary adjustments. Purchase accounting and valuation of assumed unvested options were incomplete at filing. Management said existing cash was expected to meet anticipated needs for at least 12 months, including after the acquisition.
  • Acquisition-related costs of $1.6 million were recorded in Q3 operating expenses. The investment portfolio was liquidated during the quarter in anticipation of the Oculii acquisition.
  • Material risks include semiconductor capacity and component shortages, longer manufacturing lead times, reliance on third-party manufacturers without long-term supply agreements, and customer order variability. Manufacturing purchase commitments were $66.0 million at quarter-end, up from $48.2 million at January 31, 2021.
  • Revenue and receivables are concentrated: distributor Wintech accounted for about 63.1% of Q3 revenue and Chicony about 13.4%. The filing also highlights COVID-19, U.S.–China export restrictions, Hong Kong logistics exposure, customer and market concentration, and risks integrating Oculii.
  • Ambarella reported no material legal proceedings, no material changes in internal control over financial reporting, and effective disclosure controls as of October 31, 2021.

Investor verification points

  • Track whether IP security and automotive demand sustains the reported revenue growth and margin improvement, and whether consumer-camera weakness continues.
  • Monitor supply availability, lead times, inventory growth, customer cancellations or excess orders, and the use and potential cost of the $66.0 million in manufacturing commitments.
  • Assess Oculii’s final purchase-price allocation, assumed equity awards, integration costs, and effect on post-acquisition cash and liquidity.
  • Review exposure to Wintech and Chicony, including collection of their respective quarter-end receivables of approximately $23.5 million and $12.4 million.
  • Consider the gap between quarterly GAAP profitability and the nine-month net loss, alongside stock-based compensation of $60.3 million for the nine months.